↓
 

Tag Archives: MSKCC

Dr. Vince Miller, on the Weighty Decision of a Move to Industry, the Barriers to Molecular Marker Testing, and Disrupting the Pricing of Cancer Therapies | BTJ-018

Hosts Jack West and Charu Aggarwal meet with Dr. Vince Miller to discuss the process of deciding to move from academia to industry, the evolution of molecular marker testing, and the potential for EQRx to break the impasse of escalating cancer drug costs. (42:53)

Audio Podcast

Dr. Samyukta Mullangi, on Paths to Improving on the Current Dysfunctional System of State-Based Medical Licensing to Work with Current Practice Needs | BTJ-013

Hosts Jack West and Charu Aggarwal discuss with Dr. Samyukta Mullangi of Memorial Sloan-Kettering the limitations of the current state-based medical licensing requirements and several potential paths to adapt to telemedicine & current practice needs. (36:02)

Audio Podcast

Dr. Jarushka Naidoo: South African TV Personality, Dublin Medical Trainee, Shakespearean Stage Actor, and Johns Hopkins Immunotherapy Toxicity Expert

Dr. Jarushka Naidoo, medical oncologist at Johns Hopkins, speaks with host Jack West about her path from childhood TV star in South Africa, to medical training and stage acting in Dublin, to US-based expert on toxicities of cancer immunotherapy. (50:30)

Dr. Greg Riely (Pt 2): Should local ablation therapy in oligometastatic or oligoprogressing cancer be incorporated into routine practice?

Dr. Greg Riely from MSKCC and Dr. Jack West review the changing role for plasma NGS and local ablation therapy (LAT) for oligometastic disease (OMD) or oligoprogressing advanced NSCLC in clinical practice. (28:11)

Dr. Greg Riely (Pt 1): Current Practice & Challenges in Execution of Genomic Testing in Lung Cancer Treatment

Dr. Greg Riely from Memorial Sloan-Kettering Cancer Center (MSKCC) chats with Dr. Jack West about current standards in molecular testing for advanced NSCLC & potential challenges in execution in translating the promise of genomics into broad practice. (19:57)

↑